Claims
- 1. The composition comprising the combination of compounds, which is ketoconazole and N-(2(R)-hydroxy-1(S)-indanyl)-2(R)-phenylmethyl-4-(S)hydroxy-5-(1-(4-(3-pyridylmethyl)-2(S)-N'-(t-butylcarboxamido)-piperazinyl))-pentaneamide, or pharmaceutically acceptable salt thereof.
- 2. A method of inhibiting HIV protease, comprising administering to suitable mammal in need of such treatment an effective amount of the composition of claim 1.
- 3. A method of preventing infection of HIV, or of treating infection by HIV or of treating AIDS or ARC, comprising administering to a suitable mammal in need of such treatment an effective amount of the composition of claim 1.
- 4. A pharmaceutical composition useful for inhibiting HIV protease, comprising an effective amount of the composition of claim 1, and a pharmaceutically acceptable carrier.
- 5. A pharmaceutical composition useful for preventing or treating infection of HIV or for treating AIDS or ARC, comprising an effective amount of the composition of claim 1, and a pharmaceutically acceptable carrier.
Parent Case Info
This is a continuation of application Ser. No. 08/135,706, now abandoned, filed on Oct. 13, 1993.
Non-Patent Literature Citations (1)
Entry |
Brockmeyer et al 1988, Clinical Immunol Immunopathol vol. 48(1) pp. 50-60-Med Abstract-AIDSline Document#: Med-88253871. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
135706 |
Oct 1993 |
|